Coronary Revascularization in Patients With Dialysis in China

Coronary RevascUlarization in Patients With End-stage Renal dIsease on dialysiS in China: a Nationwide and multicEnter Cohort Study.

China patients in end stage renal disease receiving maintenance dialysis have a high risk of cardiovascular disease (CVD), with a prevalence of 45.5% approximately, and coronary artery disease (CAD) has been identified as the most common one. It remains unclear that what their treatment status is and whether this group of patients can benefit from revascularization in China. The investigators plan to recruit around 30 hospitals from 7 regions as study centers, which represent different levels of economic development in Mainland China. The detailed information includes demographics, medical history, coronary angiogram, in-hospital treatment and procedures, short-term and long-term outcomes. The aim of the study is to provide the real world knowledge about current status of coronary revascularization and prognosis in patients with CAD and dialysis.

Inclusion Criteria:

• Aged 18 or above and 85 or below.
• Receives peritoneal dialysis or hemodialysis more than 1-time weekly and for more than 3 months.
• Diagnosed with coronary artery disease, including STEMI, NST-ACD, stable coronary artery disease.

Exclusion Criteria:

• Pregnancy or lactation.
• Can't be cooperative because of a mental illness or other reasons.
• Malignant tumor or severe hepatic disease.
• Life expectancy is less than 1 year.